Clinical trials for Aspergillosis

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Aspergillosis. For all clinical trials, go to clinical trials search

This list shows clinical trials for Aspergillosis

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Aspergillosis
Title Recruitment status Location
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease Recruiting United Kingdom
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945 Recruiting United Kingdom
King's invasive aspergillosis study II (KIASII) Recruiting United Kingdom
A PROSPECTIVE, RANDOMIZED TRIAL COMPARING THE SAFETY, TOLERABILITY, AND EFFICACY OF VORICONAZOLE AND ANIDULAFUNGIN IN COMBINATION TO THAT OF VORICONAZOLE ALONE WHEN USED FOR PRIMARY THERAPY OF INVASIVE ASPERGILLOSIS IN PEDIATRIC SUBJECTS AGED 2 TO 17 YEARS Not Recruiting United Kingdom
Diagnostic and Management Strategies for Invasive Aspergillosis Not recruiting United Kingdom
A PROSPECTIVE, RANDOMIZED TRIAL COMPARING THE SAFETY, TOLERABILITY, AND EFFICACY OF VORICONAZOLE AND ANIDULAFUNGIN IN COMBINATION TO THAT OF VORICONAZOLE ALONE WHEN USED FOR PRIMARY THERAPY OF INVASIVE ASPERGILLOSIS IN PEDIATRIC SUBJECTS AGED 2 TO 17 YEARS Not Recruiting United Kingdom
A Multicenter, Open, Phase II Study to Estimate the activity and safety of Caspofungin CASP in the Firstline Treatment of probable and proven Invasive Aspergillosis IA in Patients with Hematological Malignances HM or recipients of autologous Haematopoietic Stem Cell Transplantation and those with allogeneic Haematopoietic Stem Cell Transplantation HSCT Not Recruiting United Kingdom
A PROSPECTIVE, RANDOMIZED TRIAL COMPARING THE EFFICACY OF ANIDULAFUNGIN AND VORICONAZOLE IN COMBINATION TO THAT OF VORICONAZOLE ALONE WHEN USED FOR PRIMARY THERAPY OF PROVEN OR PROBABLE INVASIVE ASPERGILLOSIS Not Recruiting United Kingdom
An exploratory, randomized, double-blind, placebo controlled study to assess the efficacy of multiple doses of omalizumab in cystic fibrosis complicated with allergic bronchopulmonary aspergillosis Not Recruiting United Kingdom
Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe Not recruiting United Kingdom

Page last reviewed: 30/09/2015

Next review due: 28/02/2018